Home Physician Specialty Brief Samples Sample: Immuno-Oncology Brief – Oncology Series

Sample: Immuno-Oncology Brief – Oncology Series

Sign up for the Oncology Series
Frequency: Weekly


Issue Date: May 17, 2016

Immuno-Oncology Brief curates and provides you with informative articles from some of the most authoritative names in health information on the specialty of oncology focusing on immuno-oncology.

March 2016 (Discovery Medicine)

Systematic Review – Full Text

NK Cell-based Immunotherapies: Awakening the Innate Anti-cancer Response

Natural killer (NK) cells are a critical component of innate immunity and are able to recognize and trigger cell death in tumors by detecting receptor expression abnormalities in transformed cells. Recent studies and clinical trials have highlighted that manipulation of NK cell activation can be used as an immunotherapy in cancer. This review provides an overview of potential immunotherapies that modulate NK cell responses against tumor metastases.

January 2016 (HealthDay News)


Nivolumab, Contact Immunotx Treats In-Transit Melanoma

Nivolumab in combination with contact immunotherapy can successfully treat in-transit melanoma, according to two case reports published online Dec. 12 in the Journal of Dermatology.

September 2015 (Medical News Today)


Deadly melanoma discovery supports immunotherapy treatment for cancer

The study involved obtaining 62 DM (desmoplastic melanoma) samples from the US and Australia, on which the researchers carried out next-generation, whole-genome and exome sequencing. The coding regions of the tumor’s genetic code were parsed “letter by letter” in order to find common mutations between the samples.


Please enter your comment!
Please enter your name here